[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Monday 27 September 2021
Salford GP Header Montage
Latest News:
RSS icon
Medicine, tablets, pills


This is an electronic version of our Formulary written in conjunction with the Medicine Management Committee and the Pharmacy department.   The purpose of the Formulary is:

  • To promote safe, rational and cost effective prescribing within the Trust.
  • To help select the most appropriate drug amongst the many available.


This formulary is intended to act as a rapid reference source.  It is intended for the guidance of medical practitioners, nurses and other healthcare workers.


For local GPs and Non-medical prescribers working in the community there is the Greater Manchester Joint Formulary produced by the Greater Manchester Medicines Management Group (GMMMG).  The formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. All medicines recommended for use in the NHS in a NICE Technology Assessment (TA) are approved for use in Greater Manchester, the GMMMG site provides a list of medicines with a positive recommendation from  NICE and provides links to these TAs in the GMMMG formulary.  In the SRFT formulary below all the drugs with a positive NICE TA that are applicable to SRFT are included in the formulary.


How to use

All medicines are listed alphabetically using the generic name where possible.  Some brand names are used.


  1. Type the drug name in the 'Keywords' box

  2. Click on the 'Search' button

  3. Within the results, click on the 'generic name' of the medicine you are looking for.

  4. Click on the 'Link' - this will take you to further information that talks about that medicine. 



Drug NameBNF CategoryComment / Usage RestrictionsDetails
Acetic Acid or AA (vinegar) 5% solutionnot BNF listedRestricted to use in endoscopy during enhanced endoscopy. This is unlicensed and will be diluted down prior to use. Approved by MMG July 2014  
Aciclovir13.10.3 Antiviral preparations  
Aciclovir5.3 Antiviral drugsFor advice on the treatment of HIV infection, contact GUM or Microbiology. The North Manchester Guidelines for Drug therapy in HIV Disease have been approved for use within SRHT. Anti-retrovirals approved for use within the Trust are listed in the attached documents. 
Aciclovir 3% Eye Ointment 4.5g11.3.3 Antivirals  
Acitretin13.5.2 Preparations for psoriasisDermatology only 
Aclidinium bromide / fomoterol fumertate dehydrateSee online BNFIndicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD. Approved October 2015 as per licensed indications for initiation by the respiratory team  
Aclidinium Bromide inhalation powder (375mcg inhalation) (Eklira Genuair) manufactured by Almirall3.1.2 Antimuscarinic bronchodilatorsApproved as a 3rd line treatment for patients intolerant to 1st and 2nd line options.   Genuair is licensed as a long acting muscarinic antagonist (LAMA- Long acting bronchodilator) as a maintenance management for patients with COPD. Eklira is available via new inhaler device (Genuair).   Restricted to initiation by respiratory or on their recommendation.   Approved by MMG May 2014  
Actikerall cutaneous solution (fluorouracil 0.5% and salicylic acid 10%)13.8 Sunscreens ad camouflagers, PhotodamageFor palpable and/or moderately thick hyperkeratotic actinic keratosis (grade I/II). For use in dermatology. Approved July 2012  
Adalimumab13.5.3 Drugs affecting the immune responseDermatology only - Follow restricted high cost drug procedure when prescribing adalimumab. In line with NICE guidance for psoriasis.                                                                Also approved for Hidradenitis Suppurativa on condition funding applied for prior to use. Contact Medicines Management Team prior to use (MMG Nov 2013) 
Adalimumab10.1.3 Drugs which suppress the rheumatic disease processRheumatology consultant only - Follow restricted high cost drug procedure when prescribing adalimumab. Contact pharmacy if unsure of this process. For use in line with NICE 


All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.